ANTIPSYCHOTIC COMBINATION THERAPIES AND COMPOSITIONS OF AN ALPHA-2 ADRENERGIC RECEPTOR ANTAGONIST AND AN ATYPICAL ANTIPSYCHOTIC NEUROLEPTIC

摘要

The present invention provides novel antipsychotic therapies and compositions useful therein and provides methods for identifying new candidate molecules for the treatment of psychosis based on the proportional binding affinities for alpha2 adrenergic and D2 dopamine receptors.